<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Receptor antagonists &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/receptor-antagonists/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 15 Jan 2026 05:59:30 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Receptor antagonists &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Chlocarbazomycins: Promising Adenosine A1 Receptor Antagonists</title>
		<link>https://bioengineer.org/chlocarbazomycins-promising-adenosine-a1-receptor-antagonists/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 15 Jan 2026 05:59:25 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Adenosine A1 receptor]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[Natural chlocarbazomycins]]></category>
		<category><![CDATA[Neuropharmacology]]></category>
		<category><![CDATA[Receptor antagonists]]></category>
		<guid isPermaLink="false">https://bioengineer.org/chlocarbazomycins-promising-adenosine-a1-receptor-antagonists/</guid>

					<description><![CDATA[Recent advancements in the realm of neuropharmacology have garnered attention as researchers have begun to delve into the intricate interactions of natural compounds with brain receptors. One such promising avenue of study is the exploration of natural chlocarbazomycins as potential antagonists of the adenosine A1 receptor. This research exemplifies an innovative fusion of ligand-based and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317081</post-id>	</item>
	</channel>
</rss>
